Mesenchymal stem cells ex vivo cultivation technologies for clinical use
- Authors: Shamanskaya T.V.1,2, Osipova E.Y.1,2, Roumiantsev S.A.1,2
-
Affiliations:
- Federal Research Center of Pediatric Hematology, Oncology and Immunology
- Moscow Stem Cells Bank
- Issue: No 3 (2009)
- Pages: 69-76
- Section: BASIC RESEARCH
- Published: 27.08.2009
- URL: https://oncohematology.abvpress.ru/ongm/article/view/779
- DOI: https://doi.org/10.17650/1818-8346-2009-0-3-69-76
- ID: 779
Cite item
Full Text
Abstract
Now mesenchymal stem cells (MSC) are more widely applied in different areas of medicine. However, despite requirement for considerable quantities of human MSC for clinical practice, there is restricted information concerning culture conditions optimization required for their production. In present article the literature review, concerning various conditions of MSC extraction and culture, is presented. Influence of culture medium, cells passage density, fetal calf serum presence or absence and other conditions on MSC proliferation is surveyed. Data concerning use of three-dimensional structures and various bioreactors for ex vivo expansion are presented. MSC multilinear differentiation features are surveyed.
About the authors
T. V. Shamanskaya
Federal Research Center of Pediatric Hematology, Oncology and Immunology; Moscow Stem Cells Bank
Author for correspondence.
Email: totti111@list.ru
Moscow
Russian FederationE. Yu. Osipova
Federal Research Center of Pediatric Hematology, Oncology and Immunology; Moscow Stem Cells Bank
Moscow
Russian FederationS. A. Roumiantsev
Federal Research Center of Pediatric Hematology, Oncology and Immunology; Moscow Stem Cells Bank
Moscow
Russian FederationReferences
Supplementary files

